Correction: Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection
Guardado en:
| Formato: | article |
|---|---|
| Lenguaje: | EN |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/24e833b84a2d4da1adf17f8a9835304d |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:24e833b84a2d4da1adf17f8a9835304d |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:24e833b84a2d4da1adf17f8a9835304d2021-11-25T21:30:05ZCorrection: Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection10.1136/jitc-2020-001225corr12051-1426https://doaj.org/article/24e833b84a2d4da1adf17f8a9835304d2021-10-01T00:00:00Zhttps://jitc.bmj.com/content/9/10/e001225corr1.fullhttps://doaj.org/toc/2051-1426BMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
| spellingShingle |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Correction: Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection |
| format |
article |
| title |
Correction: Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection |
| title_short |
Correction: Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection |
| title_full |
Correction: Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection |
| title_fullStr |
Correction: Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection |
| title_full_unstemmed |
Correction: Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection |
| title_sort |
correction: tisagenlecleucel infusion in patients with relapsed/refractory all and concurrent serious infection |
| publisher |
BMJ Publishing Group |
| publishDate |
2021 |
| url |
https://doaj.org/article/24e833b84a2d4da1adf17f8a9835304d |
| _version_ |
1718410018326315008 |